Montreal, H1T 1C8, QC,
Canada
Montreal Health Innovations Coordinating Center (MHICC) Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Montreal Health Innovations Coordinating Center (MHICC) and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 100 Montreal Health Innovations Coordinating Center (MHICC) employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Montreal Health Innovations Coordinating Center (MHICC) has purchased the following applications: ArisGlobal LifeSphere MultiVigilance for Environment, Health and Safety (EHS) in 2024, ArisGlobal LifeSphere Reporting and Analytics for Analytics and BI in 2024, Microsoft 365 for Collaboration in 2022 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Montreal Health Innovations Coordinating Center (MHICC) is running and its propensity to invest more and deepen its relationship with ArisGlobal , Microsoft , Google or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Montreal Health Innovations Coordinating Center (MHICC) revenues, which have grown to $10.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Montreal Health Innovations Coordinating Center (MHICC) intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| ArisGlobal | Legacy | ArisGlobal LifeSphere MultiVigilance | Environment, Health and Safety (EHS) | HCM | n/a | 2024 | 2024 |
In 2024, Montreal Health Innovations Coordinating Center implemented ArisGlobal LifeSphere MultiVigilance as a Platform for Individual Case Safety Report to expand its service offering into post-market pharmacovigilance for biopharma clients. The implementation aligns with MHICC’s strategic move to add safety services alongside its existing pre-market clinical activities and is provisioned via ArisGlobal’s cloud CRO partnership model to provide on-demand access and configuration flexibility.
ArisGlobal LifeSphere MultiVigilance was deployed together with Reporting & Analytics, establishing an end-to-end automation-based safety platform that supports standard case intake, case processing workflows, regulatory reporting, and analytics. The configuration emphasizes workflow automation and next-generation generative AI capabilities for accelerated adverse event case processing, while Reporting & Analytics provides structured safety data views and analytics to support signal evaluation and client reporting.
Operational coverage centers on MHICC’s pharmacovigilance activities offered to multinational pharmaceutical and biotech clients, complementing the CRO’s clinical services across therapeutic areas including cardiology, oncology, neurology, gastroenterology, and endocrinology. The cloud deployment model was used to enable rapid provisioning and tailored capability sets appropriate to a CRO operating across academic and commercial sponsor engagements, without embedding unnecessary features.
Governance and rollout were described as collaborative and tailored, with ArisGlobal working closely with MHICC to configure the ideal combination of capabilities for a CRO workflow, preserving flexibility while standardizing safety case management processes. The stated outcome of the implementation is enabling MHICC to bring new safety services to market while leveraging automation and Reporting & Analytics to improve operational efficiency and differentiation in its pharmacovigilance proposition.
|
Analytics and BI
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| ArisGlobal | Legacy | ArisGlobal LifeSphere Reporting and Analytics | Analytics and BI | Analytics and BI | n/a | 2024 | 2024 |
In 2024 Montreal Health Innovations Coordinating Center (MHICC) selected ArisGlobal LifeSphere Reporting and Analytics as part of a broader adoption of ArisGlobal LifeSphere MultiVigilance to expand into post-market pharmacovigilance services. The decision positions ArisGlobal LifeSphere Reporting and Analytics at the center of MHICC’s new safety services offering for biopharma clients, with the year linked directly to the announced selection and strategic expansion into safety operations.
The implementation centers on two complementary applications, LifeSphere MultiVigilance and the ArisGlobal LifeSphere Reporting and Analytics module, deployed via the Cloud under ArisGlobal’s CRO partnership model. Functional capabilities emphasized in the selection include end-to-end automation-based adverse event processing, next-generation AI-assisted case handling, and centralized reporting and analytics workflows, consistent with the Reporting & Analytics application category and pharmacovigilance operational terminology.
Integration scope is defined around embedding the MultiVigilance platform and Reporting & Analytics into MHICC’s planned pharmacovigilance activities, enabling the CRO to offer safety case processing and post-market surveillance alongside its existing pre-market clinical services. The announced architecture relies on cloud access and tailored configuration, allowing MHICC to provision a subset of LifeSphere capabilities customized for CRO use, while maintaining linkage between automation-driven case management and analytics reporting outputs.
Governance and rollout emphasize close vendor collaboration to tailor features to CRO-specific requirements, cloud-based access controls, and a phased service introduction into safety operations for biopharma clients. Public statements from MHICC highlight the platform’s configurability and efficiency, noting LifeSphere’s automation and Generative AI capabilities as aligned with their pharmacovigilance plans, and framing Reporting & Analytics as the analytic backbone for the new safety services.
|
Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2022 | 2022 |
|
CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Tag Management | CRM |
|
2024 | 2024 |
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2022 | 2022 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2022 | 2022 |
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||